Xvivo Perfusion AB(DE:3XV)
€18.17-0.24 (-1.30%)
DE:3XV
Xvivo Perfusion AB earnings date
€18.17
At close:-0.24 (-1.30%)
Xvivo Perfusion AB (3XV) Q2 2024 Earnings Report
0 Followers
DE:3XV Q2 2024 EPS Results
- Actual EPS
- EUR 0.09
- Consensus EPS
- EUR 0.06
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 0.02
DE:3XV Q2 2024 Revenue Results
- Actual Revenue
- EUR 19.00M
- Expected Revenue
- EUR 17.50M
- Beat/Miss
- Beat by +EUR 1.50M
- YoY Revenue Growth
- +36.08%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/12/2024
- Time
- Before Open
- Conference Call
- Friday, July 12, 2024
DE:3XV Upcoming Earnings
Xvivo Perfusion AB's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:3XV Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3XV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q4) | 0.08- | 0.09 | ― | ― |
| Oct 22, 2026 | 2026 (Q3) | 0.060.13 | 0.02 | 448.64% (+0.10) | |
| Jul 14, 2026 | 2026 (Q2) | 0.070.05 | 0 | 940.00% (+0.04) | |
| Apr 24, 2026 | 2026 (Q1) | 0.090.10 | -0.04 | 391.14% (+0.14) | |
| Jan 27, 2026 | 2025 (Q4) | 0.060.09 | 0.1 | -9.91% (-0.01) | |
| Oct 23, 2025 | 2025 (Q3) | 0.040.02 | 0.25 | -90.69% (-0.23) | |
| Jul 11, 2025 | 2025 (Q2) | 0.060.00 | 0.09 | -95.00% (-0.09) | |
| Apr 24, 2025 | 2025 (Q1) | 0.07-0.04 | 0.07 | -151.97% (-0.10) | |
| Jan 28, 2025 | 2024 (Q4) | 0.130.10 | 0.2 | -47.27% (-0.09) | |
| Oct 24, 2024 | 2024 (Q3) | 0.070.25 | 0.01 | 2660.00% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


